Literature DB >> 14586011

Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration.

Heather A Arnett1, Ying Wang, Glenn K Matsushima, Kinuko Suzuki, Jenny P-Y Ting.   

Abstract

Tumor necrosis factor alpha (TNFalpha), a proinflammatory cytokine, was shown previously to promote remyelination and oligodendrocyte precursor proliferation in a murine model for demyelination and remyelination. We used Affymetrix microarrays in this study to identify (1) changes in gene expression that accompany demyelination versus remyelination and (2) changes in gene expression during the successful remyelination of wild-type mice versus the unsuccessful attempts in mice lacking TNFalpha. Alterations in inflammatory genes represented the most prominent changes, with major histocompatibility complex (MHC) genes dramatically enhanced in microglia and astrocytes during demyelination, remyelination, and as a consequence of TNFalpha stimulation. Studies to examine the roles of these genes in remyelination were then performed using mice lacking specific genes identified by the microarray. Analysis of MHC-II-null mice showed delayed remyelination and regeneration of oligodendrocytes, whereas removal of MHC-I had little effect. These data point to the induction of MHC-II by TNFalpha as an important regulatory event in remyelination and emphasize the active inflammatory response in regeneration after pathology in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586011      PMCID: PMC6740899     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination.

Authors:  J L Mason; J J Jones; M Taniike; P Morell; K Suzuki; G K Matsushima
Journal:  J Neurosci Res       Date:  2000-08-01       Impact factor: 4.164

2.  TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis.

Authors:  G Kassiotis; M Pasparakis; G Kollias; L Probert
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

3.  TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors: 
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

Review 4.  The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

Authors:  G K Matsushima; P Morell
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

5.  Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.

Authors:  G C Suvannavejh; H O Lee; J Padilla; M C Dal Canto; T A Barrett; S D Miller
Journal:  Cell Immunol       Date:  2000-10-10       Impact factor: 4.868

6.  Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury.

Authors:  U Scherbel; R Raghupathi; M Nakamura; K E Saatman; J Q Trojanowski; E Neugebauer; M W Marino; T K McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 7.  Genetics of multiple sclerosis.

Authors:  T Fukazawa; H Sasaki; S Kikuchi; T Hamada; K Tashiro
Journal:  Biomed Pharmacother       Date:  2000-03       Impact factor: 6.529

8.  Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.

Authors:  M K Njenga; P D Murray; D McGavern; X Lin; K M Drescher; M Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  1999-01       Impact factor: 3.685

9.  Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1.

Authors:  H P Eugster; K Frei; R Bachmann; H Bluethmann; H Lassmann; A Fontana
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

10.  Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination.

Authors:  G Kassiotis; G Kollias
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  58 in total

Review 1.  Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Authors:  Martin Stangel; Corinna Trebst
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.

Authors:  Sheila R Plant; Ying Wang; Sophie Vasseur; J Cameron Thrash; Eileen J McMahon; Daniel T Bergstralh; Heather A Arnett; Stephen D Miller; Monica J Carson; Juan L Iovanna; Jenny P-Y Ting
Journal:  Glia       Date:  2006-04-01       Impact factor: 7.452

Review 3.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.

Authors:  Oleg Butovsky; Gennady Landa; Gilad Kunis; Yaniv Ziv; Hila Avidan; Nadav Greenberg; Adi Schwartz; Igor Smirnov; Ayala Pollack; Steffen Jung; Michal Schwartz
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

5.  Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.

Authors:  Neus Franco-Pons; Jordi Tomàs; Bárbara Roig; Carme Auladell; Lourdes Martorell; Elisabet Vilella
Journal:  J Mol Neurosci       Date:  2008-10-04       Impact factor: 3.444

6.  MHC class II exacerbates demyelination in vivo independently of T cells.

Authors:  Meenaxi M Hiremath; Vivian S Chen; Kinuko Suzuki; Jenny P Y Ting; Glenn K Matsushima
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 7.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

8.  Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair.

Authors:  Juan Carlos Biancotti; Shalini Kumar; Jean de Vellis
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

Review 9.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 10.  Debris clearance by microglia: an essential link between degeneration and regeneration.

Authors:  H Neumann; M R Kotter; R J M Franklin
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.